A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA
| Autor: | Hans Wolff, Roberto Monarca, Lara Tavoschi, Éamonn O'Moore, Giordano Madeddu, Anouk M. Oordt-Speets, Sergio Babudieri, Marije Vonk Noordegraaf-Schouten, Marialinda Montanari, Hilde Vroling, Dagmar Hedrich |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
Sustained Virologic Response Hepatitis C virus media_common.quotation_subject Population Hepatitis C/drug therapy/epidemiology Prison Cochrane Library medicine.disease_cause Antiviral Agents 03 medical and health sciences 0302 clinical medicine Individual health Virology Europe HCV prison treatment Hepatology Infectious Diseases Prevalence medicine Humans media_common.cataloged_instance European Union 030212 general & internal medicine European union education ddc:613 media_common Antiviral Agents/economics/therapeutic use education.field_of_study business.industry Health Care Costs Grey literature Hepatitis C Patient Acceptance of Health Care medicine.disease Treatment Outcome Prisons Family medicine 030211 gastroenterology & hepatology business |
| Zdroj: | Journal of Viral Hepatitis, Vol. 25, No 12 (2018) pp. 1406-1422 |
| ISSN: | 1352-0504 |
| DOI: | 10.1111/jvh.12998 |
| Popis: | Hepatitis C prevalence in prison populations is much higher than in the community. Effective hepatitis C treatment within this population does not only have a direct individual health benefit, but may lead to substantial community dividend. We reviewed available evidence on hepatitis C treatment in prison settings, with a focus on the European Union/European Economic Area. A systematic review of the literature (PubMed, EMBASE, Cochrane library) was performed and complemented with searches for conference abstracts and grey literature. Thirty-four publications were included reporting on the effectiveness, acceptability and economic aspects of hepatitis C virus treatment models of care to achieve treatment completion and sustained viral response in prison settings. Available evidence shows that hepatitis C treatment in prison settings is feasible and the introduction of direct-acting antivirals will most likely result in increased treatment completion and better clinical outcomes for the prison population, given the caveats of affordability and the need for increased funding for prison health, with the resulting benefits accruing mostly in the community. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |